Literature DB >> 2728994

Subcutaneous mastectomy data: a final statistical analysis of 1500 patients.

V R Pennisi, A Capozzi.   

Abstract

A statistical analysis of 1500 patients who underwent subcutaneous mastectomy is presented. Their data suggest that most patients who were treated by subcutaneous mastectomy had proliferative fibrocystic disease or macrocystic disease, among other high risk factors. The data also suggest that a thoroughly performed subcutaneous mastectomy is an effective means of providing prophylaxis in women who are at high risk for breast cancer. Conclusions were confirmed by many unsolicited comments of patients who underwent the procedure and were grateful to their doctors who performed it.

Entities:  

Mesh:

Year:  1989        PMID: 2728994     DOI: 10.1007/bf01570320

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  13 in total

1.  [Breast sclero-elastotic focal lesions simulating infiltrating carcinoma].

Authors:  V Eusebi; A Grassigli; F Grosso
Journal:  Pathologica       Date:  1976 Nov-Dec

2.  Subcutaneous mastectomy data: a preliminary report.

Authors:  V R Pennisi; A Capozzi; F M Perez
Journal:  Plast Reconstr Surg       Date:  1977-01       Impact factor: 4.730

3.  The prevention of breast cancer by subcutaneous mastectomy.

Authors:  V R Pennisi
Journal:  Surg Clin North Am       Date:  1977-10       Impact factor: 2.741

4.  Early phases in the development of breast cancer.

Authors:  H S Gallager; J E Martin
Journal:  Cancer       Date:  1969-12       Impact factor: 6.860

5.  Treatment of chronic cystic disease of the breast by subcutaneous mastectomy.

Authors:  V R Pennisi; A Capozzi
Journal:  Plast Reconstr Surg       Date:  1973-11       Impact factor: 4.730

6.  Obscure breast carcinoma encountered in subcutaneous mastectomies.

Authors:  V R Pennisi; A Capozzi; J Walsh; N Christensen
Journal:  Plast Reconstr Surg       Date:  1971-01       Impact factor: 4.730

7.  Subcutaneous mastectomy and fibrocystic disease of the breast.

Authors:  V R Pennisi
Journal:  Clin Plast Surg       Date:  1976-04       Impact factor: 2.017

8.  Subcutaneous mastectomy: an interim report on 1,244 patients.

Authors:  V R Pennisi; A Capozzi
Journal:  Ann Plast Surg       Date:  1984-04       Impact factor: 1.539

9.  Elastosis in benign sclerosing ductal proliferation of the female breast.

Authors:  G Tremblay; R H Buell; T A Seemayer
Journal:  Am J Surg Pathol       Date:  1977-06       Impact factor: 6.394

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  18 in total

1.  Nipple-Sparing Mastectomy - Extended Indications and Limitations.

Authors:  Markus Niemeyera; Johannes Ettla; Birgit Plattnera; Rainer Schmida; Daniel Müllerb; Hans-Günther Machensb; Marion Kiechlea; Stefan Paepkea
Journal:  Breast Care (Basel)       Date:  2010-08-06       Impact factor: 2.860

2.  Prophylactic mastectomy: deliverance or delusion? We don't know, so we need to start registering all cases now.

Authors:  I S Fentiman
Journal:  BMJ       Date:  1998-11-21

3.  The socially constructed breast: breast implants and the medical construction of need.

Authors:  N Jacobson
Journal:  Am J Public Health       Date:  1998-08       Impact factor: 9.308

4.  The practice of prophylactic mastectomy: a survey of Maryland surgeons.

Authors:  F Houn; K J Helzlsouer; N B Friedman; M E Stefanek
Journal:  Am J Public Health       Date:  1995-06       Impact factor: 9.308

Review 5.  Hereditary breast and ovarian cancer: review and future perspectives.

Authors:  Michael P Lux; Peter A Fasching; Matthias W Beckmann
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

Review 6.  Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.

Authors:  R E Heisey; J C Carroll; E Warner; D R McCready; V Goel
Journal:  Can Fam Physician       Date:  1999-01       Impact factor: 3.275

7.  Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.

Authors:  Judy C Boughey; Tanya L Hoskin; Amy C Degnim; Thomas A Sellers; Joanne L Johnson; Melanie J Kasner; Lynn C Hartmann; Marlene H Frost
Journal:  Ann Surg Oncol       Date:  2010-09-19       Impact factor: 5.344

8.  Nipple-sparing mastectomies: Clinical outcomes from a single academic institution.

Authors:  Barbara Dull; Leah Conant; Terence Myckatyn; Marissa Tenenbaum; Amy Cyr; Julie A Margenthaler
Journal:  Mol Clin Oncol       Date:  2017-04-04

Review 9.  Clinical management of women at increased risk for breast cancer.

Authors:  V G Vogel; A Yeomans; E Higginbotham
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

10.  Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene.

Authors:  Susanne Taucher; Michael Gnant; Raimund Jakesz
Journal:  Langenbecks Arch Surg       Date:  2003-02-21       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.